Bryan T. Greene, Ph.D.
Affiliations: | 2003 | Wake Forest University School of Medicine, Winston-Salem, NC, United States |
Area:
OncologyGoogle:
"Bryan Greene"Mean distance: (not calculated yet)
Parents
Sign in to add mentorSuzy V. Torti | grad student | 2003 | Wake Forest School of Medicine | |
(Mechanistic studies of tachpyridine, a novel iron chelator and potential anti-cancer agent.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hughes AD, Marshall JR, Keller E, et al. (2014) Differential drug responses of circulating tumor cells within patient blood. Cancer Letters. 352: 28-35 |
Greene BT, Hughes AD, King MR. (2012) Circulating tumor cells: the substrate of personalized medicine? Frontiers in Oncology. 2: 69 |
Hughes AD, Mattison J, Powderly JD, et al. (2012) Rapid isolation of viable circulating tumor cells from patient blood samples. Journal of Visualized Experiments : Jove. e4248 |
Hughes AD, Mattison J, Western LT, et al. (2012) Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. Clinical Chemistry. 58: 846-53 |
Alexander RL, Greene BT, Torti SV, et al. (2005) A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms. Cancer Chemotherapy and Pharmacology. 56: 15-21 |
Buss JL, Greene BT, Turner J, et al. (2004) Iron chelators in cancer chemotherapy. Current Topics in Medicinal Chemistry. 4: 1623-35 |
Zhao R, Planalp RP, Ma R, et al. (2004) Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Biochemical Pharmacology. 67: 1677-88 |
Greene BT, Thorburn J, Willingham MC, et al. (2002) Activation of caspase pathways during iron chelator-mediated apoptosis. The Journal of Biological Chemistry. 277: 25568-75 |
Abeysinghe RD, Greene BT, Haynes R, et al. (2001) p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Carcinogenesis. 22: 1607-14 |